Navigation Links
NAIRO Supports Uniform Health Carrier External Review Model Act Adopted by NAIC
Date:6/10/2008

Consistent external review processes will benefit consumers, regulators and

the healthcare industry

LANSDALE, Pa., June 10 /PRNewswire/ -- Lack of consistency related to the external appeal process is a big issue facing healthcare reform, says NAIRO (National Association of Independent Review Organizations), a trade organization for IROs. While 44 states and Washington, D.C. have external review laws, each is different. A nation-wide standard would provide consumers with greater consistency in the appeal process when an insurer denies coverage. Widely varying external review laws can significantly affect consumers, and unnecessarily increase healthcare complexity.

Standardization of independent medical peer review processes, timeframes, methods, and credentialing requirements throughout the United States is a important issue on the NAIRO agenda. It is why NAIRO supports the National Association of Insurance Commissioners (NAIC) "Uniform Health Carrier External Review Model Act," which moves external review toward a common process for all states and reduces healthcare confusion.

"NAIRO fully supports NAIC's approval of its External Review Model Act," said Joyce Muller, NAIRO president. "It's in the best interest of regulators, the healthcare industry and consumers to simplify the overly complex external review processes that most states use to protect consumers."

NAIRO is also a proponent of the requirement that nationally accredited independent review organizations perform the reviews. "We believe the healthcare consumer benefits if nationally accredited IRO's are selected for this process," said Muller. "Accredited IRO's undergo an exhaustive process that ensures consumers will receive the highest quality independent review of their denied claim." Today many policy makers recognize that private accreditation ensures their constituencies receive quality health care.

URAC (formerly the Utilization Revi
'/>"/>

SOURCE National Association of Independent Review Organizations
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. HealthFitness CEO Supports Move Toward Cultural Shift, and Science-Based Health Management Programming
2. Diageo Supports First Ever National We Dont Serve Teens Week
3. The Prem Rawat Foundation Supports Disaster-Relief Efforts in Mozambique
4. Discovery supports theory of Alzheimers disease as form of diabetes
5. Study Supports Change to Prostate Cancer Biopsy
6. Kim & Scotts Gourmet Pretzels(TM) Supports Breast Cancer Organizations With Its New Pink Ribbon Pretzel
7. NIH grant supports UCSF research exploring early HIV infection
8. Grant Supports Study of Abnormal Ring-Shaped Chromosomes
9. Adaptis Supports Local Yakima-Based YWCA and National Diabetes
10. XShares Supports Parkinsons Disease Foundation 50th Anniversary Educational Symposium
11. $4 million AHRQ grant supports research to improve hospital care
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Ambit Biosciences Corporation Presents Phase I Clinical Results of AC220 in Patients With Acute Myeloid Leukemia at ASH Conference 2Ambit Biosciences Corporation Presents Phase I Clinical Results of AC220 in Patients With Acute Myeloid Leukemia at ASH Conference 3Ambit Biosciences Corporation Presents Phase I Clinical Results of AC220 in Patients With Acute Myeloid Leukemia at ASH Conference 4ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 2ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 3ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 4ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 5ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 6ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 7FDA Makes Interim Recommendations to Address Concern of Excess Radiation Exposure during CT Perfusion Imaging 2FDA Makes Interim Recommendations to Address Concern of Excess Radiation Exposure during CT Perfusion Imaging 3Rampant helper syndrome 9100 1Rampant helper syndrome 9100 2Virus resistant grapevines 9098 1Virus resistant grapevines 9098 2Ferns took to the trees and thrived 9095 1Ferns took to the trees and thrived 9095 2